These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1213 related articles for article (PubMed ID: 21658760)

  • 1. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
    Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
    Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of carbon tetrachloride-induced acute hepatic failure by transplantation of induced pluripotent stem cells without reprogramming factor c-Myc.
    Chang HM; Liao YW; Chiang CH; Chen YJ; Lai YH; Chang YL; Chen HL; Jeng SY; Hsieh JH; Peng CH; Li HY; Chien Y; Chen SY; Chen LK; Huo TI
    Int J Mol Sci; 2012; 13(3):3598-3617. PubMed ID: 22489170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antioxidant capacity of dental pulp-derived iPSC-differentiated hepatocytes and liver regeneration by injectable HGF-releasing hydrogel in fulminant hepatic failure.
    Chiang CH; Wu WW; Li HY; Chien Y; Sun CC; Peng CH; Lin AT; Huang CS; Lai YH; Chiou SH; Hung SI; Chang YL; Lan YT; Liu DM; Chien CS; Huo TI; Lee SD; Wang CY
    Cell Transplant; 2015; 24(3):541-59. PubMed ID: 25668102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
    Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
    Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of high quality of hepatocyte-like cells from induced pluripotent stem cells with Parp1 but lacking c-Myc.
    Huang CS; Lin HC; Lu KH; Wu WW; Yang YC; Yang YP; Chiang CH; Hsieh JH; Chang YL; Lee SD
    J Chin Med Assoc; 2018 Oct; 81(10):871-877. PubMed ID: 30017813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells without c-Myc reduce airway responsiveness and allergic reaction in sensitized mice.
    Wang CY; Chiou GY; Chien Y; Wu CC; Wu TC; Lo WT; Chen SJ; Chiou SH; Peng HJ; Huang CF
    Transplantation; 2013 Dec; 96(11):958-65. PubMed ID: 23989473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of carboxymethyl-hexanoyl chitosan, cationic polyurethane-short branch PEI in miR122 gene delivery: accelerated differentiation of iPSCs into mature hepatocyte-like cells and improved stem cell therapy in a hepatic failure model.
    Chien Y; Chang YL; Li HY; Larsson M; Wu WW; Chien CS; Wang CY; Chu PY; Chen KH; Lo WL; Chiou SH; Lan YT; Huo TI; Lee SD; Huang PI
    Acta Biomater; 2015 Feb; 13():228-44. PubMed ID: 25463491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
    Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
    Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
    Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
    Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
    Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
    Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
    J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
    Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
    Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated systems biology approach identifies positive cofactor 4 as a factor that increases reprogramming efficiency.
    Jo J; Hwang S; Kim HJ; Hong S; Lee JE; Lee SG; Baek A; Han H; Lee JI; Lee I; Lee DR
    Nucleic Acids Res; 2016 Feb; 44(3):1203-15. PubMed ID: 26740582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivation of induced pluripotent stem cells from orangutan skin fibroblasts.
    Ramaswamy K; Yik WY; Wang XM; Oliphant EN; Lu W; Shibata D; Ryder OA; Hacia JG
    BMC Res Notes; 2015 Oct; 8():577. PubMed ID: 26475477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming of adult human neural stem cells into induced pluripotent stem cells.
    Xie LQ; Sun HP; Wang T; Tang HL; Wang P; Zhu JH; Yao ZW; Feng XY
    Chin Med J (Engl); 2013 Mar; 126(6):1138-43. PubMed ID: 23506594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCNT versus iPSCs: proteins and small molecules in reprogramming.
    Han F; Li X; Song D; Jiang S; Xu Q; Zhang Y
    Int J Dev Biol; 2015; 59(4-6):179-86. PubMed ID: 26505250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.